Efficacy of em la cream to reduce fear and pain associated with interferon beta-la injection in patients with multiple sclerosis

Journal of Neuroscience Nursing

Volumn 38, Issue 4, 2006, Pages 222-226

  Buhse, Marijean ^a,b  

^a Stony Brook Medicine   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; BETA1A INTERFERON; EMLA; IMMUNOLOGICAL ADJUVANT; LIDOCAINE; LOCAL ANESTHETIC AGENT; PRILOCAINE;

ADOLESCENT; ADULT; ARTICLE; ATTITUDE TO HEALTH; CLINICAL NURSING RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; FEAR; FEMALE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; OINTMENT; PAIN; PAIN ASSESSMENT; PILOT STUDY; PSYCHOLOGICAL ASPECT; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; ANESTHETICS, LOCAL; ATTITUDE TO HEALTH; CLINICAL NURSING RESEARCH; CROSS-OVER STUDIES; FEAR; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; INTERFERON-BETA; LIDOCAINE; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; OINTMENTS; PAIN; PAIN MEASUREMENT; PILOT PROJECTS; PRILOCAINE; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 33748672277     PISSN: 08880395     EISSN: None     Source Type: Journal    
DOI: 10.1097/01376517-200608000-00004     Document Type: Article

References (17)

1. Burks, J., & Johnson, K. (Eds.). (2000). Multiple sclerosis: Diagnosis, medical management and rehabilitation. New York: Demos Medical Publishing.
2. Cooper, C. M., Gerrish, S. P., Hardwick, M., & Kay, R. (1987). EMLA cream reduces the pain of venepuncture in children. European Journal of Anaesthesiology, 4, 441-448.
3. Costello, K., Halper, J., Harris, C., & Kennedy, P. (2003). Multiple sclerosis: Long-term adherence to complex treatments. International Journal of MS Care, 5(Suppl.), 5-19.
4. Fischer, J. S., Priore, R. L., Jacobs, L. D., Cookfair, D. L., Rudick, R. A., & Herndon, R. M. (2000). Neuropsychological effects of interferon P-1a in relapsing multiple sclerosis. Annals of Neurology, 48, 885-892.
5. Hadjimichaeal, O., & Vollmer, T. L. (1999). Adherence to injection therapy in MS: Patients survey. Neurology, 52(Suppl. 2), A549.
6. Hanas, R., & Ludvigsson, J. (1997). Experience of pain from insulin injections and needle phobia in young patients with IDDM. Practical Diabetes International, 14(4), 95-99.
7. Himelstein, B. P., Canaan, A., Blackall, C. S., Zhao, H., Cava-lieri, G., & Cohen, D. E. (1996). Topical application of lidocaine-prilocaine (EMLA) cream reduces the pain of intramuscular infiltration of saline solution. Journal of Pediatrics, 129, 718-721.
8. Holland, N., Weisel, P., & Cavallo, P. (2001). Adherence to disease-modifying therapy in multiple sclerosis: Part 1. Rehabilitation Nursing, 26, 172-176.
9. IFNP Multiple Sclerosis Study Group. (1993). Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: I.-Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. Neurology, 43, 655-661.
10. IFNP Multiple Sclerosis Study Group & University of British Columbia MS/MRI Analysis Group. (1995). Interferon beta-1b in the treatment of multiple sclerosis: Final outcome of the randomized controlled trial. Neurology, 45, 1277-1285.
11. Jacobs, L. D., Beck, R. W., Simon, J. H., Kinkel, R. P., Brownscheidle, C. M., Murray, T. M., et al. (2000). Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. New England Journal of Medicine, 343, 898-904.
12. Jacobs, L. D., Cookfair, D. L., Rudick, R. A., Herndon, R. M., Rich-ert, J. R., Salazar, A. M., et al. (1996). Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. Annals of Neurology, 39(3), 285-294.
13. National Multiple Sclerois Society. (2005). Living with MS. Retrieved November 11, 2005, from www.nationalmssociety.org/treatments. asp.
14. Pasero, C. L., Davies, P., Faucett, J., & Wong, D. L. (1995). Pain control: Overcoming ʼneedle phobia’ with EMLA. American Journal of Nursing, 95(2), 24.
15. PRISMS Study Group. (1998). Randomised double-blind placebo-controlled study of interferon P-1a in relapsing/remitting multiple sclerosis. Lancet, 352, 1498-1504.
16. Revill, S. I., Robinson, J. O., Rosen, M., & Hogg, M. I. (1976). The reliability of a linear analogue for evaluating pain. Anaesthesia, 31, 1191-1198.
17. Rudick, R. A., Fisher, E., Lee, J.-C., Simont, J., & Jacobs, L. (1999). Use of the brain parenchymal fraction to measure whole brain